carbostyril has been researched along with Hepatitis A in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bugnon, S; Godinho, R; Gracin, T; Tataw, J | 1 |
Abraham, OC; Balaji, V; George, IA; Kapil, A; Karthik, R; Mitra, S | 1 |
2 other study(ies) available for carbostyril and Hepatitis A
Article | Year |
---|---|
Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin; a case report.
Topics: Acute Kidney Injury; Anti-HIV Agents; Cobicistat; Drug Combinations; Drug Interactions; Dyslipidemias; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Hepatitis A; Hepatitis C; HIV Infections; Humans; Hypolipidemic Agents; Liver Function Tests; Male; Middle Aged; Quinolones; Renal Dialysis; Rhabdomyolysis; Simvastatin; Tenofovir; Treatment Outcome | 2019 |
Quinolone-resistant Salmonella enterica Serovar typhi presenting as acute fulminant hepatitis.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Hepatitis A; Humans; Liver Failure, Acute; Male; Microbial Sensitivity Tests; Quinolones; Salmonella typhi; Typhoid Fever | 2009 |